Olympic silver medallist Liz McColgan swapped her trainers for more glamorous footwear to attend a special event celebrating the achievements of leading blood cancer charity Leukaemia & Lymphoma Research.
The former athlete was among the guests at a Celebration Evening held at City Inn, Glasgow on 3 June, which highlighted the charity’s groundbreaking research into leukaemia, lymphoma and myeloma.
Liz is patron of Leukaemia & Lymphoma Research’s running team, the Banana Army, which now raises more than £2 million every year from events all over the UK.
She was joined by the Lord Provost and Ron Cox, General Manager of City Inn, Glasgow, which is supporting the charity by donating £5 for each of its afternoon teas sold between Wednesday 19 May and Saturday 19 June.
The evening included talks by leading research scientists and local fundraisers from the charity’s Glasgow Branch, which has raised a remarkable total of more than £2 Million towards beating blood cancers since it was founded in 1970.
Fiona Murphy, 42, became involved with the branch after she was diagnosed with acute myeloid leukaemia (AML) at the age of 19 while at university. She says: “Years of research went in to making my treatment possible - something for which I’m very grateful.
"The six months of chemotherapy I received were tough but without it I wouldn’t be here today. Leukaemia & Lymphoma Research’s work makes a massive difference to patients in Scotland and I will keep fundraising for as long as I can to make sure it continues”.
Leukaemia & Lymphoma Research currently has over £3.5 million invested in research in Glasgow, including projects at the University of Glasgow, where researchers are investigating how common viruses may affect the development of Hodgkin lymphoma in children and adults.
Yvonne Dickson, Leukaemia & Lymphoma Research Manager in Scotland, says: “It was wonderful to meet just some of the thousands of people in Scotland dedicated to beating blood cancers.
"Thanks to their efforts we are able to continue vital research into better treatments and cures for patients with leukaemia, lymphoma and myeloma."